Clinical trial
Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer
NCT00420394 · Soroka University Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00420394 |
|---|---|
| Title | Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer |
| Official title | Phase II Study of Preoperative Chemotherapy and Postoperative Chemo-Radiation for Newly Diagnosed, Potentially Resectable Gastric Cancer |
| Lead sponsor | Soroka University Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stomach Neoplasms |
| Intervention type | Procedure |
| Interventions | Chemotherapy, surgery, radiotherapy |
| Enrollment | 30 |
| Start date | Apr 1, 2007 |
| First posted | Jan 11, 2007 |
| Last update posted | Jun 20, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: